Storm Riders Network - Into This World We're Thrown
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
News & Publications - Storm Riders Network
WEBCatch up on the latest news in breast cancer research. The links below will direct you to trusted sources including various peer-reviewed online publications, scientific papers, and academic articles. You can also search for articles within the following categories:
NCT04215978: Safety and Preliminary ... - Storm Riders Network
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
NCT04739670: Evaluating the Efficacy and Safety of Bevacizumab ...
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
NCT04042480: A Study of SGN-CD228A in Advanced Solid Tumors
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
NCT04707196: A Study of Abemaciclib in Indian ... - Storm Riders …
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
NCT05245500: Phase 1/2 Study of MRTX1719 in Solid Tumors …
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
Society for Neuro-Oncology (SNO) Annual Meeting
WEBNovember 17, 2022 - November 20, 2022. Join the Society for Neuro-Oncology for the Annual Meeting on November 16-20, 2022 in Tampa, Florida. The Annual Meeting will also feature a variety of sessions for early career professionals, and opportunities for networking and special sessions on diversity, equity and inclusion.
NCT04975958: Double/Triple Combinations of AN2025, AN0025 …
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...
NCT05382559: A Study of ASP3082 in Adults With ... - Storm …
WEBLatest News. Researchers engineer cells to destroy malignant tumor cells but leave the rest alone. June 28, 2021 Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer. June 15, 2021 ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to ...